Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy (Q57912000)

Christoph Roesli

9

0 references

Dario Neri

Dario Neri

8

0 references

Carol Forsblom

5

Carol Forsblom

0 references

Beatrice Borgia

2

Beatrice Borgia

0 references

author name string

Csaba Révész

3

0 references

Mária Godó

4

0 references

Peter Hamar

6

0 references

Harry Holthöfer

https://api.crossref.org/works/10.1038%2FKI.2011.116

7

0 references

language of work or name

English

0 references

publication date

August 2011

0 references

published in

Kidney International

0 references

volume

80

0 references

issue

3

0 references

page(s)

272-281

0 references

1 reference

7 January 2021

Type 1 diabetes: recent developments

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Transforming growth factor beta contributes to progressive diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Histopathology of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Treatment options for end stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Calmodulin-induced early-onset diabetes in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Alterations of the podocyte proteome in response to high glucose concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

A Chemical Proteomics Approach for the Identification of Accessible Antigens Expressed in Human Kidney Cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Two-dimensional mass spectrometric mapping

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

DeepQuanTR: MALDI-MS-based label-free quantification of proteins in complex biological samples

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Gene expression profiles of human proximal tubular epithelial cells in proteinuric nephropathies.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Urinary excretion of glycosaminoglycans and albumin in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Diabetes mellitus: a hypercoagulable state

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Differentially displayed proteins as a tool for the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Identification and proteomic profiling of exosomes in human urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Tamm-Horsfall protein in patients with kidney damage and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Uromucoid (Tamm-Horsfall glycoprotein) forms different polymeric arrangements on a filter surface under different physicochemical conditions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Markers of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

A proteomic approach for the identification of vascular markers of liver metastasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

PECAM-1: a multi-functional molecule in inflammation and vascular biology

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Neuropilins: structure, function and role in disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Identification of vasculature-specific genes by microarray analysis of Etsrp/Etv2 overexpressing zebrafish embryos.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

The nephrin-based slit diaphragm: new insight into the signalling platform identifies targets for therapy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Podocyte biology in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021

Organization of the pronephric kidney revealed by large-scale gene expression mapping.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.116

7 January 2021